Tissuemed Ltd

What Tissuemed Ltd does

Tissuemed Ltd is a UK-based medical technology company founded in 1985 and headquartered in Leeds. The company develops tissue-based therapeutic devices and bioadhesive films used in surgical procedures. Its core technology is a self-adhesive, transparent surgical sealant film platform that seals and reinforces against air leaks, fluid leakage, and cerebrospinal fluid (CSF) leakage across three indication areas: dura mater repair in neurosurgery (TissuePatchDural), thoracic surgery air leak sealing for both open and minimally invasive procedures (TissuePatch), and soft tissue fluid/blood leakage management (TissuePatchSF). The products are ready-to-use films requiring no additional preparation or equipment.

The company has been acquired by Becton, Dickinson and Company (BD), a major global medical device company. BD holds the trademarks for the TissuePatch product line and handles global commercialization through its medical device sales infrastructure, with regional sales contacts across the US/Canada, Europe, the Middle East and Africa, China, Japan, Greater Asia, Brazil, and Latin America. Product inquiries and complaints are routed through BD's regional representatives. Marketing channels include BD's product website, medical conference presence, and direct field sales representatives targeting hospitals and surgical centers.

Tissuemed's revenue model centers on one-time sales of surgical sealant film products to hospitals and surgical centers performing neurosurgical, thoracic, and general surgical procedures. Pricing is not publicly disclosed. The company operates with 11-50 employees and serves the broader surgical sealant market, which is projected to grow from USD 3.09 billion in 2025 to USD 5.86 billion by 2035 at a 6.6% CAGR, driven by chronic disease prevalence, critical care expansion, and home-based healthcare adoption.

Name

Tissuemed Ltd

Legal name

Tissuemed Ltd

Website

https://tissuemed.com

Company type

Private

Founded year

1985

Operating status

Acquired

Headcount range

11–50 employees

Short description

Tissuemed Ltd is a UK-based medical technology company that develops self-adhesive surgical sealant films (TissuePatch, TissuePatchDural, TissuePatchSF) for neurosurgical, thoracic, and soft tissue procedures. The company has been acquired by Becton, Dickinson and Company, which now commercializes the products globally through its medical device sales network.

Ownership category

akta.pro rank

Product category

Surgical Sealant Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips) (HLAHALAD)

Keywords

• Surgical sealant films
• Tissue adhesive devices
• Dural repair products
• Thoracic sealing devices
• Medical bioadhesive technology

Headquarters

HQ city

Leeds

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel

Revenue model

1. Surgical Sealant Film Products: Revenue generated from the sale of TissuePatch surgical sealant film products for dural, thoracic, and soft tissue sealing applications in surgical settings.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Tissuemed Ltd develops and manufactures self-adhesive surgical sealant film products used to seal and reinforce against air, fluid, and blood leakage during surgical procedures. Its TissuePatch product line (TissuePatchDural™, TissuePatch™, and TissuePatchSF) addresses dura mater repair in neurosurgery, air leakage in thoracic surgery, and low-pressure bleeding or fluid leakage in soft tissue procedures. The products are ready-to-use transparent films commercialised globally through Becton, Dickinson and Company (BD).

Product overview

Tissuemed Ltd (now distributed through BD - Becton, Dickinson and Company) offers a portfolio of surgical sealant film products. The product line includes three distinct products: TissuePatchDural™ Sealant Film, designed specifically for dura mater repair and CSF/blood leakage sealing; TissuePatch™ Sealant Film, intended for thoracic surgery and soft tissue procedures; and TissuePatchSF, which combines indications for both dura mater repair and thoracic/soft tissue applications. These are ready-to-use, self-adhesive transparent films that provide surgical sealing and reinforcement capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• TissuePatch: Surgical sealant film product line for sealing air leakage in thoracic surgery, dura mater repair, and soft tissue procedures.
• TissuePatchDural
• TissuePatchSF

Products and services

• TissuePatchDural™ Sealant Film

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Becton, Dickinson and Company (BD)coreOEM/ Whitelabel/ Licensing PartnerBD commercializes Tissuemed's TissuePatch surgical sealant film technology through its global medical device distribution network. BD markets and sells TissuePatch, TissuePatchDural, and TissuePatchSF products via its sales infrastructure across US/Canada, Europe, Middle East, Africa, China, Japan, Greater Asia, Brazil, and Latin America. BD holds the trademarks for TissuePatch products.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Becton, Dickinson and Company (BD): BD is the parent company that acquired Tissuemed and now commercializes the TissuePatch product family through its global sales force. As a multi-billion-dollar medical device incumbent, BD serves the same hospital surgical customer base with overlapping surgical and infection-prevention products, including other sealants and closure devices.
• Baxter International: Baxter markets Tisseel and other surgical sealants and hemostats used in thoracic, abdominal, and general surgical procedures, directly competing with TissuePatch in soft tissue and thoracic sealing applications. As a large incumbent, Baxter offers a comparable portfolio breadth.
• Ethicon (Johnson & Johnson): Ethicon markets Evicel and other surgical sealant products within J&J's MedTech division. Ethicon is a major competitor in the same hospital surgical sealing category, with substantially broader scale and a large direct sales force.

Direct peers

• Integra LifeSciences: Integra's DuraSeal dural sealant system directly competes with TissuePatchDural in neurosurgical CSF leak prevention. Both companies target the same surgical sealing use case in the same hospital customer segment, making Integra one of the closest direct comparables.

Emerging players

• Artivion: Artivion (formerly CryoLife) is involved in surgical sealants and hemostats and serves similar cardiac and thoracic surgical customers. Its BioGlue product competes in adjacent surgical sealing applications, particularly where tissue sealing and reinforcement are required.
• Cohera Medical: Cohera is a smaller specialty player developing synthetic absorbable surgical sealants for plastic and reconstructive surgery applications. Its technology overlaps with TissuePatch's soft tissue sealing use case, making it a niche peer in the surgical sealant category.
• Adhesys Medical: Adhesys Medical develops polyurethane-based tissue adhesives and sealants for surgical use. Its technology targets similar use cases to Tissuemed's TissuePatch, including soft tissue sealing and hemostasis, making it a relevant emerging competitor.
• LifeBond: LifeBond developed surgical sealants and hemostatic products targeting general and laparoscopic surgical applications. Its LifeSeal product directly overlapped with surgical sealant film categories, positioning it as a comparable niche technology peer.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/tissuemed
• Facebookfacebook.com/tissuemed

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tissuemed Ltd